| Literature DB >> 35342777 |
Marcela María Mercado-Reyes1, Marcela Daza1, Angélica Pacheco1, María Ximena Meneses-Gil1, Marisol Galindo1, Jenssy Catama1, Luz Stefany Botero1, Lyda Muñoz1, German Quinche1, Martha Lucía Ospina1.
Abstract
Background. Understanding COVID-19 dynamics in Colombia during the first pandemic year (2020) gives important insights surrounding population's exposure risk and specific susceptibilities. Seroprevalence studies can aid in having a broader understanding of the disease, offering a more inclusive view of the pandemic's impact across the population. Methods. A population-based cross-sectional study to assess antibodies against SARS-CoV-2 in 10 Colombian cities was developed between September and December 2020. Cities were grouped according development typology (Robust (RD), Intermediate (ID) and Incipient (InD)). Detection of total antibodies (IgM + IgG) against SARS-CoV-2 was employed. Univariate Odds Ratios (OR) were estimated for antibody results and selected variables. Results. About 3124 children aged between 5 and 17 years were included. Factors related to lower seropositive results were affiliation to the employer-based health insurance in RD and ID cities (OR: 0.579, 95% CI 0.477-0.703, OR: 0.648, 95%CI 0.480-0.874 respectively) and living in a household with adequate access to public services only for ID cities (OR: 0.679. 95% CI 0.491-0.939). Higher seropositivity rates in RD and ID cities were seen in children belonging to the low socioeconomic stratum (RD: OR: 1.758, 95% CI 1.427-2.165; ID: OR: 2.288, 95% CI 1.599-3.275) and living in an overcrowded household (RD: OR: 1.846, 95% CI 1.467-2.323; ID: OR: 2.379, 95% CI 1.769-3.199). Conclusions. Children and adolescents showed substantial impact from the COVID-19 pandemic. Disadvantageous living conditions were found to be significantly related to having a positive SARS-CoV-2 antibody test. These results highlight the need to prioritize vulnerable populations in the context of health emergencies.Entities:
Keywords: SARS-CoV-2; antibody; pediatric; seroepidemiology study; serology
Year: 2022 PMID: 35342777 PMCID: PMC8941708 DOI: 10.1177/2333794X221085385
Source DB: PubMed Journal: Glob Pediatr Health ISSN: 2333-794X
Selected Individual and Household Characteristics of the Population of Children Aged 5 to 17 Years Included in the SARS-CoV-2 Antibody Seroprevalence Study in 10 Colombian Cities.
| Characteristic | Barranquilla (n = 315) | Bogotá (n = 651) | Bucaramanga (n = 170) | Cali (n = 312) | Cúcuta (n = 271) | Guapí (n = 194) | Ipiales (n = 230) | Leticia (n = 369) | Medellín (n = 341) | Villavicencio (n = 271) | Total (n = 3124) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| Sex | ||||||||||||||||||||||
| Male | 162 | 51.4 | 327 | 50.2 | 78 | 45.9 | 134 | 42.9 | 134 | 49.4 | 85 | 43.8 | 105 | 45.7 | 180 | 48.8 | 177 | 56.4 | 126 | 46.5 | 1508 | 48.3 |
| Female | 153 | 48.6 | 324 | 49.8 | 92 | 54.1 | 178 | 57.1 | 137 | 50.6 | 109 | 56.2 | 125 | 54.3 | 189 | 51.2 | 164 | 52.2 | 145 | 53.5 | 1616 | 51.7 |
| Age | ||||||||||||||||||||||
| 5-11 years | 146 | 46.3 | 277 | 42.5 | 75 | 44.1 | 156 | 50.0 | 126 | 46.5 | 77 | 39.7 | 103 | 44.8 | 189 | 51.2 | 162 | 51.6 | 128 | 47.2 | 1439 | 46.1 |
| 12-7 years | 169 | 53.7 | 374 | 57.5 | 95 | 55.9 | 156 | 50.0 | 145 | 53.5 | 117 | 60.3 | 127 | 55.2 | 186 | 50.4 | 179 | 57.0 | 143 | 52.8 | 1691 | 54.1 |
| Health insurance type | ||||||||||||||||||||||
| Employer-based | 114 | 36.2 | 455 | 69.9 | 87 | 51.2 | 116 | 37.2 | 86 | 31.7 | 36 | 18.6 | 63 | 27.4 | 132 | 35.8 | 172 | 54.8 | 134 | 49.4 | 1395 | 44.6 |
| Subsidized | 183 | 58.1 | 128 | 19.7 | 69 | 40.6 | 172 | 55.1 | 139 | 51.3 | 143 | 73.7 | 157 | 68.3 | 230 | 62.3 | 135 | 43.0 | 123 | 45.4 | 1479 | 47.3 |
| No insurance | 15 | 4.8 | 36 | 5.5 | 11 | 6.5 | 22 | 7.1 | 42 | 15.5 | 11 | 5.7 | 10 | 4.3 | 3 | 0.8 | 26 | 8.3 | 6 | 2.2 | 182 | 5.8 |
| No data | 3 | 1.0 | 32 | 4.9 | 3 | 1.8 | 2 | 0.6 | 4 | 1.5 | 4 | 2.1 | 0 | 0.0 | 4 | 1.1 | 8 | 2.5 | 8 | 3.0 | 68 | 2.2 |
| Previous COVID-19 diagnosis | ||||||||||||||||||||||
| No | 309 | 98.1 | 595 | 91.4 | 169 | 99.4 | 304 | 97.4 | 265 | 97.8 | 194 | 100.0 | 228 | 99.1 | 357 | 96.7 | 325 | 95.3 | 260 | 95.9 | 3006 | 96.2 |
| Yes | 6 | 1.9 | 15 | 2.3 | 0 | 0.0 | 5 | 1.6 | 6 | 2.2 | 0 | 0.0 | 0 | 0.0 | 12 | 3.3 | 11 | 3.2 | 4 | 1.5 | 59 | 1.9 |
| No data | 0 | 0.0 | 41 | 6.3 | 1 | 0.6 | 3 | 1.0 | 0 | 0.0 | 0 | 0.0 | 2 | 0.9 | 0 | 0.0 | 5 | 1.5 | 7 | 2.6 | 59 | 1.9 |
| Educational Backwardness | ||||||||||||||||||||||
| Yes | 40 | 12.7 | 90 | 13.8 | 38 | 22.4 | 41 | 13.1 | 65 | 24.0 | 53 | 27.3 | 38 | 16.5 | 65 | 17.6 | 64 | 20.4 | 41 | 15.1 | 535 | 17.1 |
| No | 269 | 85.4 | 507 | 77.9 | 132 | 77.6 | 266 | 85.3 | 196 | 72.3 | 139 | 71.6 | 188 | 81.7 | 299 | 81.0 | 268 | 85.4 | 225 | 83.0 | 2489 | 79.7 |
| No data | 6 | 1.9 | 54 | 8.3 | 0 | 0.0 | 5 | 1.6 | 10 | 3.7 | 2 | 1.0 | 4 | 1.7 | 5 | 1.4 | 9 | 2.9 | 5 | 1.8 | 100 | 3.2 |
| Socio economic level | ||||||||||||||||||||||
| Low | 238 | 75.6 | 425 | 65.3 | 87 | 51.2 | 201 | 64.4 | 232 | 85.6 | 191 | 98.5 | 158 | 68.7 | 283 | 76.7 | 231 | 73.6 | 179 | 66.1 | 2225 | 71.2 |
| Middle-high | 66 | 21.0 | 208 | 32.0 | 74 | 43.5 | 111 | 35.6 | 36 | 13.3 | 1 | 0.5 | 68 | 29.6 | 80 | 21.7 | 110 | 35.0 | 90 | 33.2 | 844 | 27.0 |
| No data | 11 | 3.5 | 18 | 2.8 | 9 | 5.3 | 0 | 0.0 | 3 | 1.1 | 2 | 1.0 | 4 | 1.7 | 6 | 1.6 | 0 | 0.0 | 2 | 0.7 | 55 | 1.8 |
| Household overcrowding | ||||||||||||||||||||||
| No | 185 | 58.7 | 586 | 90.0 | 148 | 87.1 | 268 | 85.9 | 189 | 69.7 | 165 | 85.1 | 200 | 87.0 | 221 | 59.9 | 261 | 83.1 | 242 | 89.3 | 2465 | 78.9 |
| Yes | 130 | 41.3 | 65 | 10.0 | 22 | 12.9 | 44 | 14.1 | 82 | 30.3 | 29 | 14.9 | 30 | 13.0 | 148 | 40.1 | 80 | 25.5 | 29 | 10.7 | 659 | 21.1 |
| Access to public services | ||||||||||||||||||||||
| No | 10 | 3.2 | 10 | 1.5 | 13 | 7.6 | 1 | 0.3 | 5 | 1.8 | 168 | 86.6 | 4 | 1.7 | 180 | 48.8 | 21 | 6.2 | 8 | 3.0 | 420 | 13.4 |
| Yes | 304 | 96.5 | 631 | 96.9 | 157 | 92.4 | 311 | 99.7 | 266 | 98.2 | 25 | 12.9 | 226 | 98.3 | 187 | 50.7 | 320 | 93.8 | 263 | 97.0 | 2690 | 86.1 |
| No data | 1 | 0.3 | 10 | 1.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 2 | 0.5 | 0 | 0.0 | 0 | 0.0 | 14 | 0.5 |
Defined as any child without school enrollment. children aged 6 to 15 years with pre-school as highest educational level and/or children older than 15 years with primary school as highest educational level.
Defined as more than 2 individuals per available bedroom in the household.
Defined as combined access to aqueduct water. electricity and sewerage services.
Figure 1.Map of Colombia displaying geographical distribution, SARS-CoV-2 seroprevalence in population aged 5 to 17 years and selected socioeconomic characteristics of the 10 cities included in the Colombian SARS-CoV-2 seroprevalence study.
SARS-CoV-2 Antibody Results and Univariate Analysis of Selected Individual and Household Characteristics of the Population of Children Aged 5 to 17 Years Included in the Colombian SARS-CoV-2 Antibody Seroprevalence Study. Results for Robust Development Cities.
| Characteristic | Barranquilla (n = 315) | Bogotá (n = 651) | Bucaramanga (n = 170) | Cali (n = 312) | Medellín (n = 341) | Villavicencio (n = 271) | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
| IgM + IgG | (+) | (−) | (+) | (−) | (+) | (−) | (+) | (−) | (+) | (−) | (+) | (−) | ||||||||||||
| Totals | 185 | 58.7 | 130 | 41.3 | 177 | 27.2 | 474 | 72.8 | 56 | 32.9 | 114 | 67.1 | 90 | 28.8 | 222 | 71.2 | 88 | 25.8 | 253 | 74.2 | 82 | 30.3 | 189 | 69.7 |
| Sex | ||||||||||||||||||||||||
| Male | 94 | 29.8 | 68 | 21.6 | 89 | 13.7 | 238 | 36.6 | 26 | 15.3 | 52 | 30.6 | 34 | 10.9 | 100 | 32.1 | 37 | 10.9 | 140 | 41.1 | 39 | 14.4 | 87 | 32.1 |
| Female | 91 | 28.9 | 62 | 19.7 | 88 | 13.5 | 236 | 36.3 | 30 | 17.6 | 62 | 36.5 | 56 | 17.9 | 122 | 39.1 | 51 | 15.0 | 113 | 33.1 | 43 | 15.9 | 102 | 37.6 |
| | .794 | .987 | .920 | 0.240 | .032 | .817 | ||||||||||||||||||
| | 0.941 (0.601-1.475) | 1.002 (0.710-1.416) | 1.033 (0.543-1.962) | 0.740 (0.448-1.223) | 0.585 (0.358-0.956) | 1.063 (0.632-1.787) | ||||||||||||||||||
| Age | ||||||||||||||||||||||||
| 5-11 years | 81 | 25.7 | 65 | 20.6 | 85 | 13.1 | 192 | 29.5 | 27 | 15.9 | 48 | 28.2 | 44 | 14.1 | 112 | 35.9 | 38 | 11.1 | 124 | 36.4 | 35 | 12.9 | 93 | 34.3 |
| 12 -17 years | 4 | 33.0 | 65 | 20.6 | 92 | 14.1 | 282 | 43.3 | 29 | 17.1 | 66 | 38.8 | 46 | 14.7 | 110 | 35.3 | 50 | 14.7 | 129 | 37.8 | 47 | 17.3 | 96 | 35.4 |
| | .276 | .084 | .451 | .803 | .346 | .323 | ||||||||||||||||||
| | 0.778 (0.496-1.221) | 1.356 (0.958-1.920) | 1.280 (0.673-2.434) | 0.939 (0.575-1.533) | 0.790 (0.485-1.288) | 0.768 (0.455-1.295) | ||||||||||||||||||
| Health insurance type | ||||||||||||||||||||||||
| Employer-based | 53 | 16.8 | 61 | 19.4 | 115 | 17.7 | 340 | 52.2 | 21 | 12.4 | 66 | 38.8 | 25 | 8.0 | 91 | 29.2 | 41 | 12.0 | 131 | 38.4 | 42 | 15.5 | 92 | 33.9 |
| Subsidized | 123 | 39.0 | 60 | 19.0 | 35 | 5.4 | 93 | 14.3 | 26 | 15.3 | 43 | 25.3 | 56 | 17.9 | 116 | 37.2 | 42 | 12.3 | 93 | 27.3 | 39 | 14.4 | 84 | 31.0 |
| | 7 | 2.2 | 8 | 2.5 | 16 | 2.5 | 20 | 3.1 | 7 | 4.1 | 4 | 2.4 | 8 | 2.6 | 14 | 4.5 | 5 | 1.5 | 21 | 6.2 | 0 | 0.0 | 6 | 2.2 |
| | 2 | 0.6 | 1 | 0.3 | 11 | 1.7 | 21 | 3.2 | 2 | 1.2 | 1 | 0.6 | 1 | 0.3 | 1 | 0.3 | 0 | 0.0 | 8 | 2.3 | 1 | 0.4 | 7 | 2.6 |
| | .009 | .636 | .067 | .042 | .155 | .950 | ||||||||||||||||||
| OR (95% CI) | 0.423 (0.262-0.685) | 0.898 (0.577-1.398) | 0.526 (0.263-1.050) | 0.569 (0.329-0.981) | 0.693 (0.417-1.149) | 0.983 (0.580-1.665) | ||||||||||||||||||
| Previous COVID-19 diagnosis | ||||||||||||||||||||||||
| Yes | 5 | 1.6 | 1 | 0.3 | 11 | 1.7 | 4 | 0.6 | 0 | 0.0 | 0 | 0.0 | 2 | 0.6 | 3 | 1.0 | 10 | 2.9 | 1 | 0.3 | 4 | 1.5 | 0 | 0.0 |
| No | 180 | 57.1 | 129 | 41.0 | 152 | 23.3 | 443 | 68.0 | 56 | 32.9 | 113 | 66.5 | 86 | 27.6 | 218 | 69.9 | 78 | 22.9 | 247 | 72.4 | 78 | 28.8 | 182 | 67.2 |
| | 0 | 0.0 | 0 | 0.0 | 14 | 2.2 | 27 | 4.1 | 0 | 0.0 | 1 | 0.6 | 2 | 0.6 | 1 | 0.3 | 0 | 0.0 | 5 | 1.5 | 0 | 0.0 | 7 | 2.6 |
| | .721 | .001 | .318 | .144 | .000 |
| ||||||||||||||||||
| OR (95% CI) | 3.583 (0.413-31.03) | 8.014 (2.514-25.54) | - | 1.689 (0.277-10.29) | 31.66 (3.990-251.2) | - | ||||||||||||||||||
| Educational Backwardness | ||||||||||||||||||||||||
| Yes | 163 | 51.7 | 106 | 33.7 | 141 | 21.7 | 366 | 56.2 | 42 | 24.7 | 90 | 52.9 | 72 | 23.1 | 194 | 62.2 | 70 | 20.5 | 198 | 58.1 | 69 | 25.5 | 156 | 57.6 |
| No | 18 | 5.7 | 22 | 7.0 | 20 | 3.1 | 70 | 10.8 | 14 | 8.2 | 24 | 14.1 | 15 | 4.8 | 26 | 8.3 | 17 | 5.0 | 47 | 13.8 | 13 | 4.8 | 28 | 10.3 |
| | 4 | 1.3 | 2 | 0.6 | 16 | 2.5 | 38 | 5.8 | 0 | 0.0 | 0 | 0.0 | 3 | 1.0 | 2 | 0.6 | 1 | 0.3 | 8 | 2.3 | 0 | 0.0 | 5 | 1.8 |
| | .062 | .271 | .561 | .208 | 0.942 | .894 | ||||||||||||||||||
| OR (95% CI) | 1.879 (0.962-3.670) | 1.348 (0.790-2.298) | 0.8 (0.376-1.700) | 0.643 (0.322-1.283) | 0.977 (0.526-1.813) | 0.952 (0.465-1.949) | ||||||||||||||||||
| Socio economic level | ||||||||||||||||||||||||
| Low | 157 | 49.8 | 81 | 25.7 | 135 | 20.7 | 290 | 44.5 | 32 | 18.8 | 55 | 32.4 | 58 | 18.6 | 143 | 45.8 | 57 | 16.7 | 174 | 51.0 | 62 | 22.9 | 117 | 43.2 |
| Middle-high | 24 | 7.6 | 42 | 13.3 | 40 | 6.1 | 168 | 25.8 | 17 | 10.0 | 57 | 33.5 | 32 | 10.3 | 70 | 25.3 | 31 | 9.1 | 79 | 23.2 | 20 | 7.4 | 70 | 25.8 |
| | 4 | 1.3 | 7 | 2.2 | 2 | 0.3 | 16 | 2.5 | 7 | 4.1 | 2 | 1.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 2 | 0.7 |
| | .000 | .001 | .058 | .996 | 0.489 | .037 | ||||||||||||||||||
| OR (95% CI) | 3.391 (1.920-5.990) | 1.955 (1.309-2.918) | 1.950 (0.973-3.909) | 1.001 (0.600-1.670) | 0.834 (0.500-1.392) | 1.854 (1.033-3.327) | ||||||||||||||||||
| Household overcrowding | ||||||||||||||||||||||||
| Yes | 84 | 26.7 | 40 | 14.6 | 20 | 3.1 | 45. | 6.9 | 12 | 7.1 | 10. | 5.9 | 17 | 5.4 | 27 | 8.7 | 24 | 7.0 | 56 | 16.4 | 8 | 3.0 | 21 | 7.7 |
| No | 101 | 32.1 | 84 | 26.7 | 157 | 24.1 | 429 | 65.9 | 44 | 25.9 | 104 | 61.2 | 73 | 23.4 | 195 | 62.5 | 64 | 18.8 | 197 | 57.8 | 74 | 27.3 | 168 | 62.0 |
| | .075 | .567 | .021 | .122 | .327 | .740 | ||||||||||||||||||
| | 1.518 (0.957-2.409) | 1.214 (0.695-2.120) | 2.836 (1.141-7.048) | 1.681 (0.866-3.266) | 1.319 (0.757-2.298) | 0.864 (0.366-2.041) | ||||||||||||||||||
| Access to public services | ||||||||||||||||||||||||
| Yes | 180 | 57.1 | 124 | 39.4 | 174 | 26.7 | 457 | 70.2 | 47 | 27.6 | 110 | 64.7 | 90 | 28.8 | 221 | 70.8 | 83 | 24.3 | 237 | 69.5 | 80 | 29.5 | 183 | 67.5 |
| No | 4 | 1.3 | 6 | 1.9 | 1 | 0.2 | 9 | 1.4 | 9 | 5.3 | 4 | 2.4 | 0 | 0.0 | 1 | 0.3 | 5 | 1.5 | 16 | 4.7 | 2 | 0.7 | 6 | 2.2 |
| | 1 | 0.3 | 0 | 0.0 | 2 | 0.3 | 8 | 1.2 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| | .222 | .839 | .000 | .261 | .829 | .493 | ||||||||||||||||||
| OR (95% CI) | 2.177 (0.601-7.876) | 3.426 (0.430-27.24) | 0.189 (0.055-0.647) | - | 1.120 (0.398-3.154) | 1.311 (0.259-6.638) | ||||||||||||||||||
Defined as any child without school enrollment, children aged 6- to 15 years with pre-school as highest educational level and/or children older than 15 years with primary school as highest educational level.
Defined as more than 2 individuals per available bedroom in the household.
Defined as combined access to aqueduct water, electricity, and sewerage services.
SARS-CoV-2 Antibody Results and Univariate Analysis of Selected Individual and Household Characteristics of the Population of Children Aged 5 to 17 Years Included in the Colombian SARS-CoV-2 Antibody Seroprevalence Study. Results for Incipient Development City.
| Characteristic | Guapí (n = 194) | |||
|---|---|---|---|---|
| n | % | n | % | |
| IgM + IgG | (+) | (−) | ||
| Totals | 118 | 60.8 | 76 | 39.2 |
| Sex | ||||
| Male | 51 | 26.3 | 34 | 17.5 |
| Female | 67 | 34.5 | 42 | 21.6 |
| | .835 | |||
| | 0.940 (0.526-1.680) | |||
| Age | ||||
| 5-11 years | 43 | 22.2 | 34 | 17.5 |
| 12-17 years | 75 | 38.7 | 42 | 21.6 |
| | .249 | |||
| | 0.708 (0.393-1.274) | |||
| Health insurance type | ||||
| Employer-based | 25 | 12.9 | 11 | 5.7 |
| Subsidized | 84 | 43.3 | 59 | 30.4 |
| | 7 | 3.6 | 4 | 2.1 |
| | 2 | 1.0 | 2 | 1.0 |
| | .240 | |||
| OR (95% CI) | 1.596 (0.729-3.494) | |||
| Previous COVID-19 diagnosis | ||||
| Yes | 0 | 0.0 | 0 | 0.0 |
| No | 118 | 60.8 | 76 | 39.2 |
| | 0 | 0.0 | 0 | 0.0 |
| | .517 | |||
| OR (95% CI) | - | |||
| Educational Backwardness | ||||
| Yes | 81 | 41.8 | 58 | 29.9 |
| No | 36 | 18.6 | 17 | 8.8 |
| | 1 | 0.5 | 1 | 0.5 |
| | .220 | |||
| OR (95% CI) | 0.659 (0.338-1.286) | |||
| Socio economic level | ||||
| Low | 117 | 60.3 | 74 | 38.1 |
| Middle-high | 1 | 0.5 | 0 | 0.0 |
| | 0 | 0.0 | 2 | 1.0 |
| | .685 | |||
| OR (95% CI) | - | |||
| Household overcrowding | ||||
| Yes | 17 | 8.8 | 12 | 6.2 |
| No | 101 | 52.1 | 64 | 33.0 |
| | .792 | |||
| | 0.897 (0.402-2.003) | |||
| Access to public services | ||||
| Yes | 15 | 7.7 | 10 | 5.2 |
| No | 102 | 52.6 | 66 | 34.0 |
| | 1 | 0.5 | 0 | 0.0 |
| | .928 | |||
| OR (95% CI) | 0.970 (0.411-2.289) | |||
Defined as any child without school enrollment, children aged 6 to 15 years with pre-school as highest educational level and/or children older than 15 years with primary school as highest educational level.
Defined as more than 2 individuals per available bedroom in the household.
Defined as combined access to aqueduct water, electricity and sewerage services.
SARS-CoV-2 Antibody Results and Univariate Analysis of Selected Individual and Household Characteristics of the Population of Children Aged 5 to 17 Years Included in the Colombian SARS-CoV-2 antibody seroprevalence study. Results for Intermediate Development Cities.
| Characteristic | Ipiales (n = 230) | Leticia (n = 369) | Cúcuta (n = 271) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | n | % | |
| IgM + IgG | (+) | (−) | (+) | (−) | (+) | (−) | ||||||
| Totals | 77 | 33.5 | 153 | 66.5 | 187 | 50.7 | 182 | 49.3 | 105 | 38.7 | 166 | 61.3 |
| Sex | ||||||||||||
| Male | 35 | 15.2 | 70 | 30.4 | 93 | 25.2 | 87 | 23.6 | 50 | 18.5 | 84 | 31 |
| Female | 42 | 18.3 | 83 | 36.1 | 94 | 25.5 | 95 | 25.7 | 55 | 20.3 | 82 | 30.3 |
| | .966 | .711 | .632 | |||||||||
| | 0.988 (0.570-1.712) | 1.080 (0.718-1.625) | 0.887 (0.544-1.447) | |||||||||
| Age | ||||||||||||
| 5-11 years | 33 | 14.3 | 70 | 30.4 | 91 | 24.7 | 92 | 24.9 | 48 | 17.7 | 78 | 28.8 |
| 12-17 years | 44 | 19.1 | 83 | 36.1 | 96 | 26.0 | 90 | 24.4 | 57 | 21.0 | 88 | 32.5 |
| | .677 | .717 | .838 | |||||||||
| | 0.889 (0.511-1.544) | 0.927 (0.616-1.394) | 0.950 (0.581-1.551) | |||||||||
| Health insurance type | ||||||||||||
| Employer-based | 23 | 10.0 | 40 | 17.4 | 48 | 13.0 | 84 | 22.8 | 28 | 10.3 | 58 | 21.4 |
| Subsidized | 52 | 22.6 | 105 | 45.7 | 137 | 37.1 | 93 | 25.2 | 51 | 18.8 | 88 | 32.5 |
| | 2 | 0.9 | 8 | 3.5 | 1 | 0.3 | 2 | 0.5 | 24 | 8.9 | 18 | 6.6 |
| | 0 | 0.0 | 0 | 0.0 | 1 | 0.3 | 3 | 0.8 | 2 | 0.7 | 2 | 0.7 |
| | .632 | .001 | .528 | |||||||||
| OR (95% CI) | 1.161 (0.630-2.139) | 0.387 (0.249-0.603) | 0.832 (0.472-1.469) | |||||||||
| Previous COVID-19 diagnosis | ||||||||||||
| Yes | 0 | 0.0 | 0 | 0.0 | 8 | 2.2 | 4 | 1.1 | 6 | 2.2 | 0 | 0.0 |
| No | 76 | 33.0 | 152 | 66.1 | 179 | 48.5 | 178 | 48.2 | 99 | 36.5 | 166 | 61.3 |
| | 1 | 0.4 | 1 | 0.4 | 0 | 0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| | .300 | .415 | .014 | |||||||||
| OR (95% CI) | - | 1.988 (0.588-6.723) | - | |||||||||
| Educational Backwardness | ||||||||||||
| Yes | 63 | 27.4 | 125 | 54.3 | 156 | 42.3 | 143 | 38.8 | 73 | 26.9 | 123 | 45.4 |
| No | 12 | 5.2 | 26 | 11.3 | 27 | 7.3 | 38 | 10.3 | 28 | 10.3 | 37 | 13.7 |
| | 2 | 3.2 | 2 | 1.6 | 4 | 1.1 | 1 | 0.3 | 4 | 1.5 | 6 | 2.2 |
| | .818 | .120 | .403 | |||||||||
| OR (95% CI) | 1.092 (0.516-2.307) | 1.535 (0.892-2.642) | 0.784 (0.443-1.386) | |||||||||
| Socio economic level | ||||||||||||
| Low | 57 | 24.8 | 101 | 43.9 | 161 | 43.6 | 122 | 33.1 | 92 | 33.9 | 140 | 51.7 |
| Middle-high | 17 | 7.4 | 51 | 22.2 | 22 | 6.0 | 58 | 15.7 | 11 | 4.1 | 25 | 9.2 |
| | 3 | 1.3 | 1 | 0.4 | 4 | 1.1 | 2 | 0.5 | 2 | 0.7 | 1 | 0.4 |
| | .104 | .000 | .298 | |||||||||
| OR (95% CI) | 1.693 (0.894-3.203) | 3.479 (2 18-5.995) | 1.493 (0.701-3.181) | |||||||||
| Household overcrowding | ||||||||||||
| Yes | 11 | 4.8 | 19 | 8.3 | 97 | 26.3 | 51 | 13.8 | 41 | 15.1 | 41 | 15.1 |
| No | 66 | 28.7 | 134 | 58.3 | 90 | 24.4 | 131 | 35.5 | 64 | 23.6 | 125 | 46.1 |
| | .691 | .000 | .122 | |||||||||
| | 1.175 (0.528-2.613) | 2.768 (1.796-4.265) | 1.953 (1.152-3.309) | |||||||||
| Access to public services | ||||||||||||
| Yes | 77 | 33.5 | 149 | 64.8 | 94 | 25.5 | 93 | 25.2 | 102 | 37.6 | 164 | 60.5 |
| No | 0 | 0.0 | 4 | 1.7 | 91 | 24.7 | 89 | 24.1 | 3 | 1.1 | 2 | 0.7 |
| | 0 | 0.0 | 0 | 0.0 | 2 | 0.5 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| | .841 | .848 | .262 | |||||||||
| OR (95% CI) | - | 0.988 (0.656-1.488) | 0.414 (0.068-2.524) | |||||||||
Defined as any child without school enrollment, children aged 6 to 15 years with pre-school as highest educational level and/or children older than 15 years with primary school as highest educational level.
Defined as more than 2 individuals per available bedroom in the household.
Defined as combined access to aqueduct water, electricity and sewerage services.
Figure 2.Forest plots showing Odds Ratios (OR) and 95% Confidence Intervals estimates for positive SARS-CoV-2 antibody results and selected socio economic and clinical variables in cities grouped by typology. Panel A Robust development typology, Panel B Intermediate development typology, and Panel C Incipient development typology.